Mona F. Arafa

817 total citations
42 papers, 538 citations indexed

About

Mona F. Arafa is a scholar working on Pharmaceutical Science, Epidemiology and Materials Chemistry. According to data from OpenAlex, Mona F. Arafa has authored 42 papers receiving a total of 538 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pharmaceutical Science, 14 papers in Epidemiology and 9 papers in Materials Chemistry. Recurrent topics in Mona F. Arafa's work include Drug Solubulity and Delivery Systems (14 papers), Liver Disease Diagnosis and Treatment (12 papers) and Crystallization and Solubility Studies (9 papers). Mona F. Arafa is often cited by papers focused on Drug Solubulity and Delivery Systems (14 papers), Liver Disease Diagnosis and Treatment (12 papers) and Crystallization and Solubility Studies (9 papers). Mona F. Arafa collaborates with scholars based in Egypt, Saudi Arabia and Switzerland. Mona F. Arafa's co-authors include Gamal M. El Maghraby, Mohammed Osman, Sanaa A. El‐Gizawy, Ebtessam A. Essa, Mahmoud El‐Bendary, Rehab Badawi, Sherief Abd‐Elsalam, Dina Hazem Ziada, Marwa Salama and Hanan Soliman and has published in prestigious journals such as Scientific Reports, International Journal of Pharmaceutics and Cells.

In The Last Decade

Mona F. Arafa

38 papers receiving 523 citations

Peers

Countries citing papers authored by Mona F. Arafa

Since Specialization

Citations

This map shows the geographic impact of Mona F. Arafa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mona F. Arafa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mona F. Arafa more than expected).

Fields of papers citing papers by Mona F. Arafa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mona F. Arafa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mona F. Arafa. The network helps show where Mona F. Arafa may publish in the future.

Co-authorship network of co-authors of Mona F. Arafa

This figure shows the co-authorship network connecting the top 25 collaborators of Mona F. Arafa. A scholar is included among the top collaborators of Mona F. Arafa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mona F. Arafa. Mona F. Arafa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Development and evaluation of fusidic acid myrrh oil organogel for the reversal of Gram-negative bacterial resistance and improvement of wound-healing potential 2025 ·Journal of Drug Delivery Science and Technology ·(unknown), (unknown), (unknown), Ghareb M. Soliman, Mona Qushawy, Mona F. Arafa, Nehal M. Elsherbiny, (unknown), ‏Helal F. Hetta, Yasmin N. Ramadan, Mohamed A. Safwat, Mohamed M. Badran, Ayman Salama	1
2	Temperature-dependent phase transition microemulsions for enhanced transdermal delivery of finasteride and silodosin 2025 ·Scientific Reports ·(unknown), Mona F. Arafa, Gamal M. El Maghraby	2
3	Bilosomes and Niosomes for Enhanced Intestinal Absorption and In Vivo Efficacy of Cytarabine in Treatment of Acute Myeloid Leukemia 2024 ·Pharmaceuticals ·(unknown), Mona F. Arafa, Walaa A. El‐Dakroury, Sultan Alshehri, Gamal M. El Maghraby	5
4	Eudragit S100 coated surfactant vesicles for boosted oral bioavailability of ticagrelor 2024 ·Journal of Drug Delivery Science and Technology ·(unknown), Mona F. Arafa, Gamal M. El Maghraby	5
5	Water in nigella oil microemulsion for enhanced oral bioavailability of linagliptin 2024 ·Drug Delivery and Translational Research ·(unknown), Mona F. Arafa, Gamal M. El Maghraby	3
6	Hot melt extrusion for enhanced dissolution and intestinal absorption of hydrochlorothiazide 2023 ·Journal of Drug Delivery Science and Technology ·(unknown), (unknown), (unknown), Mona F. Arafa, Gamal M. El Maghraby, Christopher McConville	4
7	Value of hepatic artery resistive index in evaluation of liver fibrosis related to non-alcoholic fatty liver diseases 2023 ·Nasser Mousa, (unknown), Mona F. Arafa, Hatem Elalfy, (unknown), Ahmed Abdel‐Razik, (unknown)	2
8	Eutectic phase transition during tablet manufacture: effect of melting point of eutectic forming drug 2023 ·Pharmaceutical Development and Technology ·(unknown), Gamal M. El Maghraby, Mona F. Arafa	2
9	Application of Design of Experiment in the Optimization of Apixaban-Loaded Solid Lipid Nanoparticles: In Vitro and In Vivo Evaluation 2023 ·AAPS PharmSciTech ·(unknown), Sanaa A. El‐Gizawy, Mohammed Osman, Mona F. Arafa	9
10	Surfactant vesicles for enhanced antitoxoplasmic effect of norfloxacin: In vitro and in vivo evaluations 2023 ·International Journal of Pharmaceutics ·(unknown), Mona F. Arafa, Dalia S. Ashour, Ebtessam A. Essa, (unknown), (unknown), Gamal M. El Maghraby	9
11	Impact of COVID-19 on mortality rate in patients with chronic liver diseases, single-centre observational study 2023 ·(unknown), (unknown), (unknown), Mona F. Arafa, (unknown)	0
12	Lopinavir-menthol co-crystals for enhanced dissolution rate and intestinal absorption 2022 ·Journal of Drug Delivery Science and Technology ·(unknown), Mona F. Arafa, (unknown), Gamal M. El Maghraby	17
13	Melting point depression for enhanced dissolution rate of eslicarbazepine acetate 2022 ·Drug Development and Industrial Pharmacy ·(unknown), Gamal M. El Maghraby, Ebtessam A. Essa, Mona F. Arafa	1
14	Niosomal versus nano-crystalline ivermectin against different stages of Trichinella spiralis infection in mice 2021 ·Parasitology Research ·(unknown), (unknown), Gamal M. El Maghraby, Mona F. Arafa, Nema A. Soliman, (unknown), (unknown)	18
15	Co-processing of Atorvastatin and Ezetimibe for Enhanced Dissolution Rate: In Vitro and In Vivo Correlation 2021 ·AAPS PharmSciTech ·Mona F. Arafa, (unknown), (unknown), Gamal M. El Maghraby	5
16	Liposomes for Enhanced Cellular Uptake of Anticancer Agents 2020 ·Current Drug Delivery ·Gamal M. El Maghraby, Mona F. Arafa	17
17	Diagnosis of cirrhosis in patients with chronic hepatitis C genotype 4: Role of ABCB11 genotype polymorphism and plasma bile acid levels 2018 ·The Turkish Journal of Gastroenterology ·Tarek Besheer, Mona F. Arafa, (unknown), Hatem Elalfy, (unknown), Khaled Zalata, Wagdi Elkashef, (unknown), (unknown), (unknown), (unknown), Hosam Zaghloul, Ahmed Abdel Khalek Abdel Razek, Mahmoud El‐Bendary	18
18	Aerosil as a novel co-crystal co-former for improving the dissolution rate of hydrochlorothiazide 2014 ·International Journal of Pharmaceutics ·Sanaa A. El‐Gizawy, Mohammed Osman, Mona F. Arafa, Gamal M. El Maghraby	82
19	Microemulsion for simultaneous transdermal delivery of benzocaine and indomethacin:in vitroandin vivoevaluation 2013 ·Drug Development and Industrial Pharmacy ·Gamal M. El Maghraby, Mona F. Arafa, Mohammed Osman	24
20	Chemical composition and nutritional effect of Physalis peruviana husk as hepato-renal protective agent 2012 ·International Journal of Phytomedicine ·S. El–Gengaihi, Manal A. Hamed, Emad Eldin Hassan, (unknown), Mona F. Arafa	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact